Foghorn Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $40.6M |
| FY2019 | $23.8M | $22.3M | $15.0M |
| FY2020 | $109.4M | $255.6M | $92.8M |
| FY2021 | $422.9M | $519.8M | $101.1M |
| FY2022 | $404.8M | $404.9M | $52.2M |
| FY2023 | $363.1M | $285.9M | $80.3M |
| FY2024 | $329.5M | $284.0M | $55.5M |
| FY2025 | $306.6M | $198.1M | $80.9M |